Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


Catalog Number Pack Size List Price* Quantity
HY-109190-5MG 5 mg Inquire
HY-109190-25MG 25 mg Inquire
HY-109190-10MG 10 mg Inquire
HY-109190-50MG 50 mg Inquire
HY-109190-100MG 100 mg Inquire

* CHF, excl. 7.7% VAT and shipping costs

Product Description

GB002; PK10571
Seralutinib (GB002) is an inhaled PDGFRα and PDGFRβ inhibitor. Seralutinib (GB002) is used in the study for pulmonary arterial hypertension.

Category Biochemicals
Supplier MedChem Express
Application Neuroscience-Neuromodulation
Regulatory Status RUO
Format Solubility: DMSO : 100 mg/mL (212.98 mM; Need ultrasonic)
Grade Clinical information: Phase 2
Molecular Formula C27H27N5O3
Molecular Weight 469.53
CAS-Number [1619931-27-9]
Storage Conditions Please store the product under the recommended conditions in the Certificate of Analysis.
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support

Business Development

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern


If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.

© Copyright 2021 Lucerna-Chem AG, Switzerland